171 related articles for article (PubMed ID: 37067947)
21. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
Miyashita N; Endo T; Onozawa M; Hashimoto D; Kondo T; Fujimoto K; Kahata K; Sugita J; Goto H; Matsukawa T; Hashino S; Teshima T
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207973
[TBL] [Abstract][Full Text] [Related]
22. The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation.
Gasior M; Ferreras C; de Paz R; Bueno D; Mozo Y; Sisinni L; Canizales JT; González B; Olivas-Mazón R; Marcos A; Romero AB; Constanzo A; Mirones I; Fernández-Arroyo A; Balas A; Vicario JL; Escudero A; Yuste VJ; Pérez-Martínez A
Transfusion; 2021 May; 61(5):1505-1517. PubMed ID: 33713461
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation.
Watanabe M; Kanda J; Hishizawa M; Kondo T; Yamashita K; Takaori-Kondo A
Biol Blood Marrow Transplant; 2019 Mar; 25(3):587-593. PubMed ID: 30359733
[TBL] [Abstract][Full Text] [Related]
24. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
Hill JA; Koo S; Guzman Suarez BB; Ho VT; Cutler C; Koreth J; Armand P; Alyea EP; Baden LR; Antin JH; Soiffer RJ; Marty FM
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1638-48. PubMed ID: 22564265
[TBL] [Abstract][Full Text] [Related]
25. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
[TBL] [Abstract][Full Text] [Related]
26. High Incidence of Early Human Herpesvirus-6 Infection in Children Undergoing Haploidentical Manipulated Stem Cell Transplantation for Hematologic Malignancies.
Perruccio K; Sisinni L; Perez-Martinez A; Valentin J; Capolsini I; Massei MS; Caniglia M; Cesaro S
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2549-2557. PubMed ID: 30067953
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients.
Pawlowska AB; Karras NA; Liu H; DiMundo J; Cheng JC; Sun W; Armenian S; Yang D; Palmer JM; Bell A; Tahoun A; Tegtmeier B; Dadwal S; Rosenthal J
Transpl Infect Dis; 2021 Feb; 23(1):e13453. PubMed ID: 32860467
[TBL] [Abstract][Full Text] [Related]
28. [Human herpesvirus-6-associated diseases in hematopoietic stem cell transplantation: an update].
Ogata M
Rinsho Ketsueki; 2016 Mar; 57(3):298-306. PubMed ID: 27076241
[TBL] [Abstract][Full Text] [Related]
29. Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor.
Crocchiolo R; Giordano L; Rimondo A; Bologna M; Sarina B; Morabito L; Bramanti S; Castagna L; Mineri R
J Clin Virol; 2016 Nov; 84():24-26. PubMed ID: 27669362
[TBL] [Abstract][Full Text] [Related]
30. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
Tormo N; Solano C; de la Cámara R; Garcia-Noblejas A; Cardeñoso L; Clari MA; Nieto J; López J; Hernández-Boluda JC; Remigia MJ; Benet I; Navarro D
Biol Blood Marrow Transplant; 2010 May; 16(5):653-61. PubMed ID: 20005968
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.
Gilles R; Herling M; Holtick U; Heger E; Awerkiew S; Fish I; Höller K; Sierra S; Knops E; Kaiser R; Scheid C; Di Cristanziano V
Med Microbiol Immunol; 2017 Oct; 206(5):355-362. PubMed ID: 28702856
[TBL] [Abstract][Full Text] [Related]
32. Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis.
Berneking L; Both A; Langebrake C; Aepfelbacher M; Lütgehetmann M; Kröger N; Christopeit M
Transpl Infect Dis; 2022 Jun; 24(3):e13836. PubMed ID: 35389547
[TBL] [Abstract][Full Text] [Related]
33. ELISPOT assay of interferon-γ secretion for evaluating human cytomegalovirus reactivation risk in allo-HSCT recipients.
Liang H; Xia J; Zhang R; Yang B; Wu J; Gui G; Huang Y; Chen X; Yang R; Wang H; Gong S; Fan J
J Med Virol; 2021 Nov; 93(11):6301-6308. PubMed ID: 34076905
[TBL] [Abstract][Full Text] [Related]
34. Late-phase human herpesvirus 6B reactivation in hematopoietic stem cell transplant recipients.
Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Yoshikawa T
Transpl Infect Dis; 2018 Aug; 20(4):e12916. PubMed ID: 29797616
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
[TBL] [Abstract][Full Text] [Related]
36. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
[TBL] [Abstract][Full Text] [Related]
37. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
[TBL] [Abstract][Full Text] [Related]
38. Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience.
Hoff FW; Chung SS; Patel PA; Premnath N; Khatib J; Tadic-Ovcina M; AhmedRabie A; Helton D; Yohannes S; Shahan J; Patel H; Geethakumari PR; Vusirikala M; Collins RH; Madanat YF
Transpl Immunol; 2023 Apr; 77():101808. PubMed ID: 36842566
[TBL] [Abstract][Full Text] [Related]
39. Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay.
Inazawa N; Hori T; Nojima M; Saito M; Igarashi K; Yamamoto M; Shimizu N; Yoto Y; Tsutsumi H
J Med Virol; 2017 Feb; 89(2):358-362. PubMed ID: 27364410
[TBL] [Abstract][Full Text] [Related]
40. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
